Abbott Labs (ABT) Stock “Buy” Rating Kept at Jefferies; The Price Target is $55.0000; Image Systems (ISNS) Has 0.33 Sentiment

June 16, 2017 - By Louis Casey

Image Sensing Systems, Inc. is a provider of software products and solutions for the intelligent transportation systems industry. The company has market cap of $18.03 million. The Firm develops and markets video and radar processing products for use in traffic, security, police and parking applications, such as intersection control, highway, bridge and tunnel traffic management, venue security, entry control and traffic data collection. It has a 14.58 P/E ratio. The Firm operates through two divisions: Intersection and Highway.

Among 17 analysts covering Abbott Laboratories (NYSE:ABT), 9 have Buy rating, 0 Sell and 8 Hold. Therefore 53% are positive. Abbott Laboratories has $90 highest and $9 lowest target. $50.25’s average target is 5.61% above currents $47.58 stock price. Abbott Laboratories had 50 analyst reports since July 24, 2015 according to SRatingsIntel. On Monday, April 17 the stock rating was maintained by Cowen & Co with “Buy”. Jefferies maintained Abbott Laboratories (NYSE:ABT) on Tuesday, September 13 with “Buy” rating. The rating was downgraded by BMO Capital Markets on Tuesday, March 14 to “Market Perform”. Jefferies maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, July 14. Jefferies has “Buy” rating and $49 target. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, January 26. On Tuesday, March 15 the stock rating was maintained by Jefferies with “Buy”. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, March 1. Barclays Capital upgraded Abbott Laboratories (NYSE:ABT) rating on Wednesday, October 7. Barclays Capital has “Overweight” rating and $52 target. The firm earned “Buy” rating on Saturday, August 29 by BTIG Research. As per Wednesday, April 19, the company rating was maintained by Stifel Nicolaus.

Bard Associates Inc holds 0.04% of its portfolio in Image Sensing Systems, Inc. for 24,360 shares. Grt Capital Partners L.L.C. owns 25,850 shares or 0.03% of their US portfolio. Moreover, Blackrock Fund Advisors has 0% invested in the company for 1,777 shares. The California-based Blackrock Institutional Trust Company N.A. has invested 0% in the stock. California Public Employees Retirement System, a California-based fund reported 31,600 shares.

The stock increased 3.03% or $0.1 on June 15, reaching $3.4. About shares traded. Image Sensing Systems, Inc. (ISNS) has risen 54.59% since June 16, 2016 and is uptrending. It has outperformed by 37.89% the S&P500.

Analysts await Image Sensing Systems, Inc. (NASDAQ:ISNS) to report earnings on August, 4.

Since December 20, 2016, it had 2 insider purchases, and 19 sales for $7.83 million activity. Shares for $1.16 million were sold by Funck Robert E. Another trade for 13,155 shares valued at $592,157 was sold by Contreras Jaime. Salvadori Daniel Gesua Sive also sold $93,776 worth of Abbott Laboratories (NYSE:ABT) on Tuesday, February 28. The insider BIRD ROGER sold $72,069. MANNING JOSEPH J sold $33,453 worth of Abbott Laboratories (NYSE:ABT) on Tuesday, February 28. $1.46 million worth of Abbott Laboratories (NYSE:ABT) was sold by Mason Heather L. 15,580 shares were bought by Blaser Brian J, worth $599,120 on Tuesday, December 20.

About 4 shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since June 16, 2016 and is uptrending. It has underperformed by 0.80% the S&P500.

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The company has market cap of $84.34 billion. The Firm operates through four divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. It has a 53.42 P/E ratio. The Company’s Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States.